Literature DB >> 30259192

Tumor Necrosis Factor-α in Heart Failure: an Updated Review.

Sarah M Schumacher1, Sathyamangla V Naga Prasad2.   

Abstract

PURPOSE OF THE REVIEW: Proinflammatory cytokines are consistently elevated in congestive heart failure. In the current review, we provide an overview on the current understanding of how tumor necrosis factor-α (TNFα), a key proinflammatory cytokine, potentiates heart failure by overwhelming the anti-inflammatory responses disrupting the homeostasis. RECENT
FINDINGS: Studies have shown co-relationship between severity of heart failure and levels of the proinflammatory cytokine TNFα and one of its secondary mediators interleukin-6 (IL-6), suggesting their potential as biomarkers. Recent efforts have focused on understanding the mechanisms of how proinflammatory cytokines contribute towards cardiac dysfunction and failure. In addition, how unchecked proinflammatory cytokines and their cross-talk with sympathetic system overrides the anti-inflammatory response underlying failure. The review offers insights on how TNFα and IL-6 contribute to cardiac dysfunction and failure. Furthermore, this provides a forum to begin the discussion on the cross-talk between sympathetic drive and proinflammatory cytokines and its determinant role in deleterious outcomes.

Entities:  

Keywords:  Beta-adrenergic receptor; Cardiac hypertrophy and dilation; G-protein coupled receptor kinases; Heart failure; Interleukins; Tumor necrosis factor alpha

Mesh:

Substances:

Year:  2018        PMID: 30259192      PMCID: PMC6311126          DOI: 10.1007/s11886-018-1067-7

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  167 in total

1.  Endotoxin-induced myocardial tumor necrosis factor-alpha synthesis depresses contractility of isolated rat hearts: evidence for a role of sphingosine and cyclooxygenase-2-derived thromboxane production.

Authors:  U Grandel; L Fink; A Blum; M Heep; M Buerke; H J Kraemer; K Mayer; R M Bohle; W Seeger; F Grimminger; U Sibelius
Journal:  Circulation       Date:  2000-11-28       Impact factor: 29.690

Review 2.  Noradrenergic and peptidergic innervation of lymphoid organs.

Authors:  S Y Felten; D L Felten; D L Bellinger; J A Olschowka
Journal:  Chem Immunol       Date:  1992

Review 3.  NF-kappaB in cardiovascular disease: diverse and specific effects of a "general" transcription factor?

Authors:  W Keith Jones; Maria Brown; Michael Wilhide; Suiwen He; Xiaoping Ren
Journal:  Cardiovasc Toxicol       Date:  2005       Impact factor: 3.231

4.  A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells.

Authors:  R A Black; C T Rauch; C J Kozlosky; J J Peschon; J L Slack; M F Wolfson; B J Castner; K L Stocking; P Reddy; S Srinivasan; N Nelson; N Boiani; K A Schooley; M Gerhart; R Davis; J N Fitzner; R S Johnson; R J Paxton; C J March; D P Cerretti
Journal:  Nature       Date:  1997-02-20       Impact factor: 49.962

5.  Arachidonic acid mediates dual effect of TNF-alpha on Ca2+ transients and contraction of adult rat cardiomyocytes.

Authors:  Aïssata Amadou; Artur Nawrocki; Martin Best-Belpomme; Catherine Pavoine; Françoise Pecker
Journal:  Am J Physiol Cell Physiol       Date:  2002-06       Impact factor: 4.249

6.  Inhibition of tumor necrosis factor-alpha improves postischemic recovery of hypertrophied hearts.

Authors:  C Stamm; I Friehs; D B Cowan; A M Moran; H Cao-Danh; L F Duebener; P J del Nido; F X McGowan
Journal:  Circulation       Date:  2001-09-18       Impact factor: 29.690

7.  Stimulation of heart contractility by supernatants from lectin-activated lymphocytes. Role of IL-2.

Authors:  S B Fink; M Finiasz; L Sterin-Borda; E Borda; M M de Bracco
Journal:  Int J Immunopharmacol       Date:  1989

Review 8.  Role of inflammation in the progression of heart failure.

Authors:  Arne Yndestad; Jan Kristian Damås; Erik Øie; Thor Ueland; Lars Gullestad; Pål Aukrust
Journal:  Curr Cardiol Rep       Date:  2007-05       Impact factor: 2.931

9.  Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart.

Authors:  T Yokoyama; L Vaca; R D Rossen; W Durante; P Hazarika; D L Mann
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

Review 10.  Proinflammatory Cytokines Mediate GPCR Dysfunction.

Authors:  Maradumane L Mohan; Neelakantan T Vasudevan; Sathyamangla V Naga Prasad
Journal:  J Cardiovasc Pharmacol       Date:  2017-08       Impact factor: 3.105

View more
  31 in total

1.  Pediatric and adult dilated cardiomyopathy are distinguished by distinct biomarker profiles.

Authors:  Kory J Lavine; Kathleen E Simpson; Melanie R F Gropler; Steven E Lipshultz; James D Wilkinson; Jeffrey A Towbin; Steven D Colan; Charles E Canter
Journal:  Pediatr Res       Date:  2021-08-17       Impact factor: 3.953

2.  A Simplified Herbal Formula Improves Cardiac Function and Reduces Inflammation in Mice Through the TLR-Mediated NF-κB Signaling Pathway.

Authors:  Xiaoming Dong; Xiaowei Han; Xiaojiao Zhang; Sijing Li; Ziru Li; Jinhua Kang; Jialin Jiang; Shihao Ni; Lu Lu; Zhiling He; Haoming Huang; Shaoxiang Xian; Tianhui Yuan; Zhongqi Yang; Wenjie Long; Zemin Wan
Journal:  Front Pharmacol       Date:  2022-06-06       Impact factor: 5.988

3.  Higher bacterial DNAemia can affect the impact of a polyphenol-rich dietary pattern on biomarkers of intestinal permeability and cardiovascular risk in older subjects.

Authors:  Giorgio Gargari; Valentina Taverniti; Cristian Del Bo'; Stefano Bernardi; Nicole Hidalgo-Liberona; Tomás Meroño; Cristina Andres-Lacueva; Paul A Kroon; Antonio Cherubini; Patrizia Riso; Simone Guglielmetti
Journal:  Eur J Nutr       Date:  2021-11-02       Impact factor: 5.614

4.  MicroRNA-103a-3p enhances sepsis-induced acute kidney injury via targeting CXCL12.

Authors:  Gaihong Ding; Jinhua An; Luyao Li
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

5.  Pro-inflammatory effects of crystalline- and nano-sized non-crystalline silica particles in a 3D alveolar model.

Authors:  Tonje Skuland; Marit Låg; Arno C Gutleb; Bendik C Brinchmann; Tommaso Serchi; Johan Øvrevik; Jørn A Holme; Magne Refsnes
Journal:  Part Fibre Toxicol       Date:  2020-04-21       Impact factor: 9.400

6.  Sex Differences in the Association Between Inflammation and Event-Free Survival in Patients With Heart Failure.

Authors:  Zyad T Saleh; Ahmad T Alraoush; Ahmad A Aqel; Tagreed O Shawashi; Misook Chung; Terry A Lennie
Journal:  J Cardiovasc Nurs       Date:  2021-07-06       Impact factor: 2.083

7.  Upregulation of COX-2 and PGE2 Induced by TNF-α Mediated Through TNFR1/MitoROS/PKCα/P38 MAPK, JNK1/2/FoxO1 Cascade in Human Cardiac Fibroblasts.

Authors:  Chuen-Mao Yang; Chien-Chung Yang; Li-Der Hsiao; Chia-Ying Yu; Hui-Ching Tseng; Chih-Kai Hsu; Jiro Hasegawa Situmorang
Journal:  J Inflamm Res       Date:  2021-06-28

8.  Suppression of Inflammatory Cardiac Cytokine Network in Rats with Untreated Obesity and Pre-Diabetes by AT2 Receptor Agonist NP-6A4.

Authors:  Madhavi P Gavini; Abuzar Mahmood; Anthony M Belenchia; Paige Beauparlant; Senthil A Kumar; Sivakumar Ardhanari; Vincent G DeMarco; Lakshmi Pulakat
Journal:  Front Pharmacol       Date:  2021-06-18       Impact factor: 5.810

9.  Withaferin A attenuates ovarian cancer-induced cardiac cachexia.

Authors:  Natia Q Kelm; Alex R Straughn; Sham S Kakar
Journal:  PLoS One       Date:  2020-07-28       Impact factor: 3.752

10.  A network analysis to identify pathophysiological pathways distinguishing ischaemic from non-ischaemic heart failure.

Authors:  Iziah E Sama; Rebecca J Woolley; Jan F Nauta; Simon P R Romaine; Jasper Tromp; Jozine M Ter Maaten; Peter van der Meer; Carolyn S P Lam; Nilesh J Samani; Leong L Ng; Marco Metra; Kenneth Dickstein; Stefan D Anker; Faiez Zannad; Chim C Lang; John G F Cleland; Dirk J van Veldhuisen; Hans L Hillege; Adriaan A Voors
Journal:  Eur J Heart Fail       Date:  2020-04-03       Impact factor: 15.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.